What is Happening in High Throughput Screening at Sygnature Discovery?

At Sygnature Discovery, our High Throughput Screening (HTS) group, established in 2019 couples industry-leading advanced laboratory automation with a fully integrated informatics platform and Genedata Screener® analysis software to provide a closed-loop workflow to facilitate the high-fidelity screening of our chemical libraries.

This poster provides an insight into the wide range of target classes, technologies and therapeutic areas we have prosecuted in prior HTS campaigns, including a high proportion of complex cell-based assays. We provide information on the quality and ongoing QC of the Sygnature compound libraries including LeadFinder Diversity 150K as well as example screening data.

Download Poster

Poster download form with organisation field
Invalid email address provided.
Please only use your business email address.